LYEL smart money

Lyell Immunopharma, INC. (LYEL): 4 insider buys, 2 top funds holding it in the public filings.

Insider buys, 12 months$75.0M

Insider buys

FiledWhoRoleAmountPrice
2026-11-05Arch Venture Partners Ix, LLC10% owner$25.0M$10.77
2026-11-05Arch Venture Fund Xiii, L.P.10% owner$25.0M$10.77
2026-03-09Arch Venture Partners Ix Overage, L.P.TenPercentOwner$12.5M$25.61
2026-03-09Berns Paul LTenPercentOwner$12.5M$25.61

Top 100 funds holding it

#FundChangeWeightValue
39Decheng Capital LLC0.99%$7M
41Alphabet INC.0.00%$3M
Open the live smart money map